Clinical Trial Update: Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated stem cell transplantation with or without the growth factor tbo-filgrastim in patients with multiple myeloma or non-Hodgkin lymphoma. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Tbo-filgrastim (tbo-filgrastim)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Non-Hodgkin's Lymphoma, Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2025-12-17